Table 2.

CD16 MoAb Binding (mean fluorescence intensities ± SD) of NK Cells From Individuals Genotyped for FcγRIIIA Polymorphisms

GenotypeMoAb
FcγRIIIA-48FcγRIIIA-158Control mIgG2aCLBFcRgran1MEM154B73.1
48LL 158FF 12 ± 6 1,539 ± 257 42 ± 20 303 ± 176 
48LL 158VF 8 ± 4 1,713 ± 719 460 ± 218* 248 ± 105 
48LR or 48LH 158VF 6 ± 2 1,443 ± 504 323 ± 182 121 ± 51 
48LR or 48LH 158VV 10 ± 5 1,102 ± 298 718 ± 341 151 ± 117 
48HH ρ 158VV 1,694 892 55 
48RR2-155 158VV 15 1,443 642 103 
GenotypeMoAb
FcγRIIIA-48FcγRIIIA-158Control mIgG2aCLBFcRgran1MEM154B73.1
48LL 158FF 12 ± 6 1,539 ± 257 42 ± 20 303 ± 176 
48LL 158VF 8 ± 4 1,713 ± 719 460 ± 218* 248 ± 105 
48LR or 48LH 158VF 6 ± 2 1,443 ± 504 323 ± 182 121 ± 51 
48LR or 48LH 158VV 10 ± 5 1,102 ± 298 718 ± 341 151 ± 117 
48HH ρ 158VV 1,694 892 55 
48RR2-155 158VV 15 1,443 642 103 

At least three donors of each genotype were tested. Data were analyzed with the Student's t-test the and Welch's approximate t-test. P values below .05 were considered significant.

*

Statistically significant difference from mean fluorescence intensity of NK cells from FcγRIIIa-158FF individuals of the same FcγRIIIA-48 genotype.

Significantly different from FcγRIIIa-48LL NK cells of the same FcγRIIIA-158 genotype.

Significantly different from FcγRIIIa-158VF NK cells of the same FcγRIIIA-48 genotype.

ρ Two individuals were tested; one healthy control and one patient suffering from recurrent viral infections.

F2-155

One healthy individual was tested.

Close Modal

or Create an Account

Close Modal
Close Modal